A Randomized Controlled Trial With Everolimus for IQ and Autism in Tuberous Sclerosis Complex
Neurology - United States
doi 10.1212/wnl.0000000000007749
Full Text
Open PDFAbstract
Available in full text
Categories
Date
June 19, 2019
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)